Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes definitely agree on that. Of course several people posting are sharing helpful links and opinions directly related to the science which of course will translate into $ if trial results repeat previous outcomes. At this point to the people that’s been invested for a while it’s probably how much more do I want to buy
I know this is putting the cart way out in front of the horse but I keep thinking of all the bumble bees that would be buzzing around if this was only available to moderate/severe. Considering all diagnosis is transferred to some code is there separate codes for mild moderate and severe. I can see where prescribing off label for ms would be a issue but drawing a line on AD perhaps no so much.
Exactly why I believe the off label demand will be huge if approved. Can you imagine the doctor saying I’m gonna give you this one that will slow it down then when you’re far enough gone we can put you on this to improve your condition
Not trying to raise doubt in the company just basically thinking out loud. It’s never the expected that bites that’s why I’ve always said I hate surprises and will until I walk in and a stripper jumps out of a cake and knowing my wife that’s never going to happen
My only real concern at this point is do they have every gate chained tight I’m highly confident the trial results will be positive but with the amount of money we’re looking at someone somewhere will try to steal it. I’m hoping the new COO was brought in to ensure it’s locked down.
They left out a few words in the key word section. Evolving conceptual theoretical. I fully believe at some point in the future AI will play a big role in drug development and testing but as of now ntrp is moving forward with the gold standard trial and previous data gives them a high probability of success
Thanks
Been a wee bit busy which is no excuse but has anyone heard anything on the npr interview
Yes not expecting a big jump in price it’s just nice to see something that reminds you why you bought in to start with and I may add a few more shares if it dips I definitely have quit saying I’m done buying I’ve broke that pledge enough
Happy to see the workaholics here sharpened their shovels and dug this up many thanks
wishing everyone a safe happy weekend
My thoughts exactly I’m all for progress but if you have a tried and true method you better be absolutely certain your new improved path doesn’t create more problems then it solves and I could give dump truck loads of examples where the new better way just screwed up a fool proof system
I vaguely remember reading once where some catholic nuns were going to donate their brains for ad research. What I don’t recall is if it was because they as a group were prone to be afflicted or just the reverse. This was several years ago
That was my guess. It was a great deal for those investors. Now drop some news and make whoever sold regret it tomorrow I did grab a few more today myself I believe I’ve bought enough now lol of course I’ve said that before
St Jude’s has a story out on als I’m not the greatest at linking these things it’s easy to find
Sure will just waiting for something about ms to be announced and see where we go
Every time so far a decent amount hits the ask it gets snatched up
I believe someone may have called that possibility in the last few days it’s certainly within reach
Yes that wasn’t too shabby at all
I would advise anyone who discounts the value of placebo to have a conversation with someone that has spent some time in the lab you may find you’ll view its effects completely different
Been tied up all morning signed on and seen that maybe I won’t login till late from now on of course the real move hasn’t started yet
A simple don’t know would have worked but hey why use two words when you can type a whole page lol
Yes even if it turned out iv was only way it’s not a problem. This is your options you can get hooked up to a iv periodically or here’s you some pills and the nursing home you’ll be staying at not to worry you won’t know you’re here pretty soon. It’s like saying a diabetic won’t take a shot or kidney dialysis is too much trouble to bother with
A bit off topic but it relates to how much is unknown about the mind take a minute and read about Edward Cayce
Memory is truly amazing I’ve always wondered when you’re trying to recall something and you just can’t quite get it maybe simple as someone’s name then perhaps 5 minutes or hours later boom you remember. You knew it but just couldn’t pull it out
You’re touching on a subject I know somewhat about. Yes they would promote anything for the right profit margin
I suppose at this point it’s impossible to say if avxl will be successful with AD I’m sure like many bios they’ve had a few setbacks but it seems they’ve had some good results convincing some investors
Great summary and if this current trial confirms previous results they’ll be no demand for a drug that slows decline
At least the people I told to buy when it was at 4 aren’t calling me a sob today
Been busy all day just looking at a nice little move looks like at this rate the 200 Dma is possible this week
Hmmm your description makes it sound like money well spent to me but everyone is entitled to their own opinion
Quite the reverse actually. After spending some time reading not about avxl or ntrp but cns disorders in general and came to the conclusion this is way bigger then AD and ntrp is hands down where I want to place my investment
Looks like new COO is coming aboard
I was just thinking if or when this is approved I’ll bet the off label prescriptions will equal or exceed it’s approved use.
I would hope they do some screening blood/urine whatever to assure it’s all clear. Considering they know it’s a problem I’m confident 30 days isn’t the minimum amount of time needed
Not sure why but I believe if a comatose patient was treated with ntrp treatment promptly got up and tap danced out the door the results would be met with but but but. As far as testing methods fda appoved is the only logical way to proceed. Perhaps someday AI will start to finish develope every drug eliminating trials completely but someday isn’t the case we’re talking about now. As of this moment ntrp is dosing patients in a fda approved trial which if successful will open the floodgates and I for one wouldn’t want to say I knew about this and passed.
Was just looking at that I belive that’s our high water mark since early December and it’s about to break
Seems like the more I read it’s easier to name cns disorders that wouldn’t be treated by ntrp as if AD isn’t enough. Basically comparable to the discovery of penicillin
Yes they do very glad to hear it’s going well.
I’m a firm believer that hard work should be well compensated